Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here:

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Default user image.

Åke Lernmark

Principal investigator

Default user image.

Genetic and perinatal factors as risk for childhood type 1 diabetes


  • K Larsson
  • Helena Larsson
  • E Cederwall
  • K Kockum
  • Sture Sjöblad
  • Bengt Lindberg
  • Barbro Lernmark
  • Corrado Cilio
  • Sten Ivarsson
  • Åke Lernmark

Summary, in English

The mechanisms by which gestational infections, blood incompatibility, birth weight, mother's age and other prenatal or neonatal events increase the risk for type 1 diabetes are not understood. Studies so far have been retrospective, and there is a lack of population-based prospective studies. The possibility identifying children at type 1 diabetes risk among first-degree relatives has resulted in prospective studies aimed at identifying postnatal events associated with the appearance of autoantibody markers for type 1 diabetes and a possible later onset of diabetes. However, the majority (85%) of new onset type 1 diabetes children do not have a first-degree relative with the disease. Population-based studies are therefore designed to prospectively analyse pregnant mothers and their offspring. One such study is DiPiS (Diabetes Prediction in Skane), which is examining a total of about 10 000 pregnancies expected every year in the Skane (Scania) region of Sweden that has 1.1 million inhabitants. Blood samples from all mothers in this region are obtained during pregnancy and at the time of delivery. Cord blood is analysed for HLA high-risk alleles and for autoantibodies against the 65 kD isoform of glutamic acid decarboxylase (GADA), the protein tyrosine phosphatase-related IA-2 antigen (IA-2A) and insulin (IAA) as a measure of prenatal autoimmune exposure. Identifying high-risk children by genetic, autoimmune and gestational risk factors followed by prospective analyses will make it possible to test the hypothesis that gestational events may trigger beta cell autoimmunity as a prerequisite for childhood type 1 diabetes. Copyright (C) 2004 John Wiley Sons, Ltd.


  • Paediatric Endocrinology
  • Neonatology
  • Paediatrics (Lund)
  • Department of Clinical Sciences, Malmö

Publishing year







Diabetes/Metabolism Research & Reviews





Document type

Journal article review


John Wiley and Sons


  • Endocrinology and Diabetes


  • transplacental transfer
  • gestational infections
  • HLA
  • autoimmunity
  • islet autoantibodies
  • blood incompatibility



Research group

  • Paediatric Endocrinology
  • Neonatology


  • ISSN: 1520-7552